EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›AIFF

AIFF

FIREFLY NEUROSCIENCE, INC.

Next earnings ≈ Aug 7, 2026 · est. from filing cadence

Hold
$1.33
▲ +6.40%
$1.33▼ -53.50%
over 1Y
L $0.64EODHDH $3.16
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.4%
1W-0.8%
1M-23.7%
3M-39.4%
YTD+48.3%
1Y-53.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
F
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)

Revenue grew 957.4% YoY; but unprofitable (net margin -1741.0%).

Revenue (FY2025) $1.14M · FY2025

FIREFLY NEUROSCIENCE, INC. shows $1.14M in FY2025 revenue (+957.4% YoY), a -1741.0% net margin, and -260.3% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$15.0M$12.0M$498K$108K$1.14M
Gross profit$3.62M$2.86M$2.61M$108K$645K
Operating income-$2.63M-$5.42M-$3.08M-$10.1M-$8.86M
Net income-$1.13M-$17.8M-$2.60M-$10.5M-$19.9M
Diluted EPS-$0.09————
Net margin-7.5%-147.7%-522.7%-9685.2%-1741.0%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$19.4M
EV / EBITDA—
EV / Sales17.0
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-101.1%
FCF yield-41.6%

Quality & risk

ROIC (est.)-86.5%
Free cash flow-$8.19M
Total debt$450K
Net cash$232K
Altman Z-Score-13.30 distress
Piotroski F-Score4/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+27.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — agreement terminated (2026-06-26). Worth a closer look.
  1. 8-K Agreement terminated2026-06-26
  2. S-3/A Shelf registration (potential raise)2026-06-23
  3. 8-K Officer / director change2026-06-22
  4. S-3 Shelf registration (potential raise)2026-05-20
  5. 10-Q Quarterly report2026-05-13
  6. 8-K Material agreement2026-05-12
  7. 8-K Material agreement2026-04-22
  8. 10-K Annual report2026-03-31
  9. 8-K Material agreement2026-03-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-252026-06-26open ↗S-3/AFiling2026-06-23open ↗8-KPeriod ending 2026-06-182026-06-22open ↗S-8Filing2026-05-20open ↗S-3Filing2026-05-20open ↗10-QPeriod ending 2026-03-312026-05-13open ↗8-KPeriod ending 2026-05-062026-05-12open ↗8-KPeriod ending 2026-04-162026-04-22open ↗DFiling2026-04-16open ↗10-KPeriod ending 2025-12-312026-03-31open ↗3/APeriod ending 2024-08-122026-03-13open ↗8-KPeriod ending 2026-03-122026-03-12open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueF
GrowthC
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$1.14M
+957.4% YoY
Net margin
-1741.0%
ROE
-260.3%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.14M+957.4%
Net income-$19.9M-90.1%
Gross profit$645K+497.2%
Operating income-$8.86M+11.9%
Diluted EPS-$0.09-400.0%
Cash & equivalents$682K-6.7%
Total assets$10.5M+127.7%
Total liabilities$2.84M-42.9%
Stockholders' equity$7.64M+2136.5%
Gross: 56.5%Op.: -775.5%L/E: 0.37x

Frequently asked

Is FIREFLY NEUROSCIENCE, INC. (AIFF) a buy?
AIFF currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 957.4% YoY; but unprofitable (net margin -1741.0%).
What is FIREFLY NEUROSCIENCE, INC.'s quality score?
AIFF scores 39.509803921568626/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000803578, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 7:29:04 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-03-10
DeCaprio David
President and COO
Award44.9K
2026-03-10
Lipschitz Gregory
Chief Executive Officer
Award66.0K
2025-10-22
Windsor Private Capital LP
10% owner
Sell78.0K @ $2.07$162K
2025-10-21
Windsor Private Capital LP
10% owner
Sell19.2K @ $2.40$46.1K
2025-10-20
Windsor Private Capital LP
10% owner
Sell33.5K @ $2.46$82.3K
2025-10-17
Windsor Private Capital LP
10% owner
Sell45.0K @ $2.55$115K
2025-10-16
Windsor Private Capital LP
10% owner
Sell40.1K @ $2.65$106K
2025-10-15
Windsor Private Capital LP
10% owner
Sell17.5K @ $2.74$48.0K
2025-10-14
Windsor Private Capital LP
10% owner
Sell29.5K @ $2.74$80.8K
2025-10-13
Windsor Private Capital LP
10% owner
Sell32.1K @ $2.65$85.2K
2025-10-10
Windsor Private Capital LP
10% owner
Sell74.8K @ $2.70$202K
2025-10-09
Windsor Private Capital LP
10% owner
Sell30.1K @ $2.94$88.7K

Earnings history

beat/miss · move
2024-12-04—▲ +2.89%8-K ↗
2024-11-15—▼ -0.31%8-K ↗
2022-11-21—▼ -5.26%8-K ↗
2022-08-15—▼ -2.42%8-K ↗
2022-05-23—▼ -13.21%8-K ↗
2022-04-18—▲ +1.33%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Firefly Neuroscience Unveils AI-Driven Biomarker Discovery For PTSDBearish
nasdaq.com· 2026-06-02
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSDBullish
globenewswire.com· 2026-06-02
With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP DepositoryBullish
finance.yahoo.com· 2026-04-13
With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP DepositoryBullish
globenewswire.com· 2026-04-13
Firefly Neuroscience Stock Surges 43% Over Advancement In Differential Diagnosis Of ADHDBullish
nasdaq.com· 2026-03-13
BC-Most Active StocksBullish
finance.yahoo.com· 2026-03-04

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score40 vs 67
Revenue growth957.4% vs 7.1%
Net margin-1741.0% vs 10.5%
Return on equity-260.3% vs 12.3%
P/E— vs 25.5